Abby Kennedy

Abby Kennedy is a seasoned expert in clinical operations with extensive experience spanning over two decades in the biopharmaceutical industry. Currently serving as the Senior Vice President of Clinical Operations at DermBiont, Inc. since July 2024, Abby has held significant leadership roles at CymaBay Therapeutics as Vice President of Clinical Operations and at Principia Biopharma as Senior Director of Clinical Operations. Previous roles include Senior Clinical Program Leader at Genentech, and various managerial positions at XOMA and Exelixis. Abby's early career included a position as Sr. Scientist and Sr. Clinical Trials Manager II at Exelixis. Additionally, Abby has contributed to the American Chemical Society as Chair and pursued advanced studies at the University of Arizona, culminating in a Ph.D. in Organic Chemistry.